Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas

Oral Oncology

Volumn 35, Issue 1, 1999, Pages 56-62

  Yao, L ^a   Iwai, M ^a   Furuta, I ^a  

^a Faculty of Medicine   (Japan)

Author keywords

Bcl 2 Expression; Immunohistochemistry; p53 Expression; Tongue squamous cell carcinoma

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CHROMOSOME 15Q; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-BCL-2; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032890023     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00055-4     Document Type: Article

References (35)

1. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis: its significance in cancer therapy. Cancer. 73:1994;2013-2026.
2. Tsujimoto Y., Finger L.R., Yunis J., Nowell P., Croce P.C. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097-1099.
3. Tsujimoto Y., Jaffe E., Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1985;1440-1443.
4. Sarbia M., Bittinger F., Porschen R., Verreet P., Dutkowski P., Willers R., et al. bcl-2 expression, prognosis in squamous cell carcinomas of the esophagus. InternationalJournal of Cancer (Pred Oncology). 69:1996;324-328.
5. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens S.C., Lee J.J., Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Research. 55:1995;237-241.
6. Pollina L., Pacini F., Fontanini G., Vignati S., Bevilacqua G., Basolo F. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. British Journal of Cancer. 73:1996;139-143.
7. Gallo O., Boddi V., Calzolari A., Simonetti L., Trovati M., Bianchi S. bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy. Clinical Cancer Research. 6:1996;261-267.
8. Jordan R.C.K., Catzavelos G.C., Barrett A.W., Speight P.M. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncology, European Journal of Cancer. 32B:(6):1996;394-400.
9. Lane D.P. The regulation of p53 function: Steiner Award Lecture. International Journal of Cancer. 57:1994;623-627.
10. Kastan M.B., Canman C.E., Leonard C.J. p53, cell cycle control and apoptosis: implications for cancer. Cancer and Metastasis Reviews. 14:(1):1995;3-15.
11. Miyashita T., Krajewski S., Krajewska M., Shabaik A., Wang H.G., Lin H.K., Liebermann D.A. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
12. Wang Y., Szekely L., Okan J., Klein G., Wiman G., Wiman K.L. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in v-myc-induced T-cell lymphoma line. Oncogene. 8:1993;3427-3431.
13. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology. 119:1992;493-501.
14. Hermanek P., Sobin L.S. UICC TNM Classification of Malignant Tumors. Berlin: Springer, 1987, p. 13-18.
15. Pindborg J.J., Reichart P.A., Smith C.J., Waal van der I. Histological Typing of Cancer and Precancer of the Oral Mucosa, 2nd Edition. World Health Organization: Springer, 1997, p. 11-13.
16. Anneroth G., Hensen L.S. Methodological study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scandinavian Journal of Dentistry Research. 92:1984;448-468.
17. Piffko J., Bankfalvi A., Öfner D., Joos U., Böcker W., Schmid K.W. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. Journal of Pathology. 176:1995;69-75.
18. Saegusa M., Takano Y., Hashimura M., Shoji Y., Okayasu I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer. 76:1995;2297-2303.
19. Costa A., Marasca R., Valentinis B., Savarino M., Faranda A., Silvestrini R., Torelli G. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. Journal of Pathology. 176:1995;45-53.
20. Harada H., Mitsuyasu T., Seta Y., Maruoka Y., Toyoshima K., Yasumoto S. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. Journal of Oral Pathology and Medicine. 27:1998;11-17.
21. Castle V.P., Heidelberger K.P., Bromberg J., Ou X., Dole M., Nuñez G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. American Journal of Pathology. 143:1993;1543-1550.
22. Furuya Y., Krajewski S., Epstein J.I., Reed J.C., Isaacs J.T. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clinical Cancer Research. 2:1996;389-398.
23. Lotem J., Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth and Differentation. 4:1993;41-47.
24. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
25. Soussi T., Legros Y., Lubin R., Ory K., Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. International Journal of Cancer. 57:1994;1-9.
26. Finlay C.A., Hinds P.W., Tan T.H., Eliyahu D., Oren M., levine A.J. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Molecular and Cellular Biology. 8:1988;531-539.
27. Iggo R., Gatter K., Bártek J., Lane D., Harris A.L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:1990;675-679.
28. Inoue M., Fujita M., Enomoto T., Morimoto H., Monden T., Shimano T., et al. Immunohistochemical analysis of p53 in gynecologic tumors. American Journal of Clinical Pathology. 102:1994;665-670.
29. Shin D.M., Lee J.S., Lippman S.M., Lee J.J., Tu Z.N., Choi G., et al. p53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. Journal of the National Cancer Institute. 88:1996;519-529.
30. Trivedy C., Warnakulasuriya K.A.A.S., Tavassoli M., Steingrimsdottir H., Penhallow J., Maher R., et al. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. Journal of Oral Pathology and Medicine. 27:1988;27-72.
31. Gasparini G., Weidner N., Maluta S., Pozza F., Boracchi P., Mezzetti M., Testolin A., Bevilacqua .P. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma. Internatinal Journal of Cancer. 55:1993;739-744.
32. Raybaud-Diogene H., Tetu B., Morency R., Fortin A., Monteil R.A. p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Oral Oncology, Eurpoean Journal of Cancer. 32B:(3):1996;143-149.
33. Warnakulasuriya K.A.A.S., Johnson N.W. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. Journal of Oral Pathology and Medicine. 23:1994;246-250.
34. Stoolwey P.J., Loole R., Hordijk G.J. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncology, European Journal of Cancer. 30B:(2):1994;138-141.
35. Kropveld A., van Mansfeld A.D., Nabben N., Hordijk G.J., Slootweg P.J. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Oral Oncology, European Journal of Cancer. 32B:(6):1996;388-393.